Table 1 Characteristics of the genome-wide association study summary data
Phenotype | Sample size | Ethnicity | Consortium/Cohort | Year of publication | PMID |
|---|---|---|---|---|---|
Chronic liver diseases | |||||
 Viral hepatitis | 377277 (2143 cases/375134 controls) | European | FinnGen R9 | 2022 | 36653562 |
 PBC | 24510 (8021 cases/16489 controls) | European | NA | 2021 | 34033851 |
 PSC | 14890 (2871 cases/12019 controls) | European | IPSCSG | 2017 | 27992413 |
 Liver cirrhosis | 374449 (1142 cases/373307 controls) | European | FinnGen R9 | 2022 | 36653562 |
 HCC | 287590 (453 cases/287137 controls) | European | FinnGen R9 | 2022 | 36653562 |
Musculoskeletal disorders | |||||
 Osteoporosis |  |  |  |  |  |
  TB-BMD | 56284 | European | GEFOS | 2018 | 29304378 |
  FN-BMD | 32735 | European | GEFOS | 2015 | 26367794 |
  LS-BMD | 28489 | European | GEFOS | 2015 | 26367794 |
  FA-BMD | 8143 | European | GEFOS | 2015 | 26367794 |
  eBMD | 426824 | European | UK Biobank | 2019 | 30598549 |
 Osteoarthritis |  |  |  |  |  |
  ALL OA | 826690 (177517 cases/649173 controls) | European (~ 98%) | GO Consortium | 2021 | 34822786 |
  Knee OA | 396054 (62497 cases/333557 controls) | European (~ 98%) | GO Consortium | 2021 | 34822786 |
  Hip OA | 353388 (36445 cases/316943 controls) | European (~ 98%) | GO Consortium | 2021 | 34822786 |
  Spine OA | 333950 (28372 cases/305578 controls) | European (~ 98%) | GO Consortium | 2021 | 34822786 |
  Hand OA | 303782 (20901 cases/282881 controls) | European (~ 98%) | GO Consortium | 2021 | 34822786 |
Sarcopenia | Â | Â | Â | Â | Â |
 ALM | 450243 | European | UK Biobank | 2020 | 33097823 |
 Grip strength | 461089 | European | MRC-IEU | 2018 | NA |
 Walking pace | 459915 | European | MRC-IEU | 2018 | NA |